Yeqing Dong

Tianjin Medical University

H指数:7

被引数:183

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Energy metabolism dysregulation in schizophrenia with non-thyroidal illness syndrome: Roles of citric acid and Tyrosol-4-sulfate

精神分裂症合并非甲状腺疾病综合征的能量代谢失调：柠檬酸和酪醇-4-硫酸盐的作用

Schizophrenia Research

IF3.5

2026-09-010

PRE

Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naive schizophrenia (vol 148, 111830, 2026)

基线代谢特征预测认知改善，纵向甘油磷酸脂变化追踪首发药物 naive 精神分裂症康复（vol 148, 111830, 2026）

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2026-08-300

PRE

Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophrenia

基线代谢特征预测认知改善，且纵向甘油磷酸脂变化追踪首发药物-naïve型精神分裂症的恢复

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2026-07-011

PRE

Metabolomics analysis reveals BMI-related metabolic characteristics in schizophrenia patients

代谢组学分析揭示了精神分裂症患者中与BMI相关的代谢特征

Schizophrenia Research

IF3.5

2026-07-010

PRE

Biological Sex Influences the Pharmacokinetics and Organ Dosimetry of 177Lu-DOTATATE: A Systematic Preclinical Evaluation

性别生物学因素影响177Lu-DOTATATE的药代动力学和器官剂量测定：一项系统性的预临床评估

Pharmaceuticals

IF4.8

2026-05-150

Plasma biomarkers in drug-naïve schizophrenia with severe cognitive impairment via targeted metabolomics

靶向代谢组学在药物初治伴有严重认知障碍的精神分裂症患者中的血浆生物标志物

Psychoneuroendocrinology

IF3.6

2025-11-250

PRE

Prediction of treatment response in drug-naïve schizophrenia patients from the perspective of targeted metabolomics

SCHIZOPHRENIA RESEARCH

IF3.5

2025-03-010

PRE

Plasma Metabolic Characteristics and Potential Biomarker Combinations in Schizophrenia Patients With Tardive Dyskinesia

SCHIZOPHRENIA BULLETIN

IF4.8

2025-02-210

PRE

Sex-specific differences in the relationship between thyroid hormones and neurocognition in schizophrenia: A large-scale cross-sectional study

PSYCHONEUROENDOCRINOLOGY

IF3.6

2025-02-010

PRE

The sex-specific relationship of ghrelin and cognition in Chinese han first-episode drug-naive major depressive disorder

JOURNAL OF NEURAL TRANSMISSION

IF4

2025-01-230

PRE

The incidence and influencing factors of recent suicide attempts in major depressive disorder patients comorbid with moderate-to-severe anxiety: a large-scale cross-sectional study

BMC PSYCHIATRY

IF3.6

2025-01-091

OAAI

The relationship of cardiovascular disease risk, clozapine antipsychotic use and cognitive function in a large Chinese schizophrenia cohort

BRAIN RESEARCH

IF2.6

2024-12-011

PRE

Sex-specific associations between 10-year cardiovascular risk, clinical symptoms and cognitive impairments in schizophrenia

JOURNAL OF NEURAL TRANSMISSION

IF4

2024-10-100

PRE

Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

IF3.7

2024-08-280

PRE

Association between peripheral plasma cytokine levels and suicidal ideation in first-episode, drug-naïve major depressive disorder

PSYCHONEUROENDOCRINOLOGY

IF3.6

2024-07-012

PRE

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

BMC PSYCHIATRY

IF3.6

2024-05-134

OAAI

Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome

SCHIZOPHRENIA

IF4.1

2024-04-160

OAAI

Does Baseline Cognitive Function Predict the Reduction Rate in HDRS-17 Total Scores in FirstEpisode, Drug-Naïve Patients with Major Depressive Disorder?

NEUROPSYCHIATRIC DISEASE AND TREATMENT

IF2.9

2024-02-010

OAAI

Metabolic biomarkers of risperidone-induced weight gain in drug-naive patients with schizophrenia

FRONTIERS IN PSYCHIATRY

IF3.2

2023-04-202

OAAI

GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma

CELL DEATH & DISEASE

IF9.6

2021-05-046

OAAI

Yeqing Dong

个人简介

教育背景

工作经历

荣誉奖项

研究方向